Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CANF

Can-Fite BioPharma

$1.67

0.004 (0.24%)

07:04
10/17/17
10/17
07:04
10/17/17
07:04
Hot Stocks
Can-Fite BioPharma issued patent in Korea for Piclidenoson in psoriasis »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
GALT

Galectin Therapeutics

$2.76

-0.02 (-0.72%)

, GNFTF

Genfit

$26.73

-1.9 (-6.64%)

04:55
10/12/17
10/12
04:55
10/12/17
04:55
Conference/Events
Hanson Wade to hold a summit »

NASH Summit Europe is…

GALT

Galectin Therapeutics

$2.76

-0.02 (-0.72%)

GNFTF

Genfit

$26.73

-1.9 (-6.64%)

BAYRY

Bayer

$34.78

0.22 (0.64%)

RHHBY

Roche

$31.56

-0.07 (-0.22%)

ONVO

Organovo

$1.68

-0.025 (-1.47%)

ICPT

Intercept

$67.57

-1.06 (-1.54%)

MEDI

Medimmune

CANF

Can-Fite BioPharma

$1.65

-0.01 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 19

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

GALT

Galectin Therapeutics

$2.78

0.17 (6.51%)

, GNFTF

Genfit

$28.63

0.33 (1.17%)

04:55
10/11/17
10/11
04:55
10/11/17
04:55
Conference/Events
Hanson Wade to hold a summit »

NASH Summit Europe is…

GALT

Galectin Therapeutics

$2.78

0.17 (6.51%)

GNFTF

Genfit

$28.63

0.33 (1.17%)

BAYRY

Bayer

$34.56

0.16 (0.47%)

RHHBY

Roche

$31.63

0.14 (0.44%)

ONVO

Organovo

$1.70

-0.25 (-12.82%)

ICPT

Intercept

$68.63

-0.56 (-0.81%)

MEDI

Medimmune

CANF

Can-Fite BioPharma

$1.66

-0.0117 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

GALT

Galectin Therapeutics

$2.61

0.17 (6.97%)

, GNFTF

Genfit

$28.30

-1.82 (-6.04%)

04:55
10/10/17
10/10
04:55
10/10/17
04:55
Conference/Events
Hanson Wade to hold a summit »

NASH Summit Europe is…

GALT

Galectin Therapeutics

$2.61

0.17 (6.97%)

GNFTF

Genfit

$28.30

-1.82 (-6.04%)

BAYRY

Bayer

$34.40

-0.06 (-0.17%)

RHHBY

Roche

$31.49

-0.24 (-0.76%)

ONVO

Organovo

$1.95

-0.09 (-4.41%)

ICPT

Intercept

$69.19

-0.725 (-1.04%)

MEDI

Medimmune

CANF

Can-Fite BioPharma

$1.67

-0.0082 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

GALT

Galectin Therapeutics

$2.44

0.01 (0.41%)

, GNFTF

Genfit

15:57
10/09/17
10/09
15:57
10/09/17
15:57
Conference/Events
Hanson Wade to hold a summit »

NASH Summit Europe is…

GALT

Galectin Therapeutics

$2.44

0.01 (0.41%)

GNFTF

Genfit

BAYRY

Bayer

$34.46

0.22 (0.64%)

RHHBY

Roche

$31.73

0.01 (0.03%)

ONVO

Organovo

$2.04

-0.03 (-1.45%)

ICPT

Intercept

$69.92

-2.845 (-3.91%)

MEDI

Medimmune

CANF

Can-Fite BioPharma

$1.67

-0.0082 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

CANF

Can-Fite BioPharma

$1.69

-0.0366 (-2.12%)

16:34
09/26/17
09/26
16:34
09/26/17
16:34
Syndicate
Breaking Syndicate news story on Can-Fite BioPharma »

Can-Fite BioPharma files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CANF

Can-Fite BioPharma

$1.74

0.02 (1.16%)

07:05
09/18/17
09/18
07:05
09/18/17
07:05
Hot Stocks
Can-Fite BioPharma files patent application for CRS treatments »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.62

-0.02 (-1.22%)

07:05
08/23/17
08/23
07:05
08/23/17
07:05
Hot Stocks
Can-Fite BioPharma receives mileston payment from CKD »

Can-Fite BioPharma …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

07:58
08/11/17
08/11
07:58
08/11/17
07:58
Initiation
Can-Fite BioPharma initiated at Maxim »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.61

0.02 (1.26%)

07:13
08/09/17
08/09
07:13
08/09/17
07:13
Hot Stocks
Can-Fite BioPharma completes patient enrollment for Phase II Namodenoson study »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.